Codis

Overview

Codis is a global contract development and manufacturing organization (CDMO) specializing in particle engineering, spray drying, and formulation expertise. Formed through the integration of Particle Dynamics (US) and the Haverhill spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.

Core Capabilities

Spray Drying & Amorphous Solid Dispersions (ASD)

• Commercial-scale solvent-based and aqueous-based spray drying
• Industry-leading expertise in designing, scaling, and manufacturing amorphous solid dispersions for improved bioavailability of poorly soluble compounds
• One of the largest GMP spray drying capacities globally across US and UK facilities

Microencapsulation

• Proprietary solvent-free microencapsulation processes using spinning disc technology
• Enhanced taste masking, stability, and controlled release capabilities
• Applications in pharmaceutical, consumer health, OTC, and nutraceutical sectors

Continuous Granulation

• High-shear, aqueous-based continuous granulation system
• Ideal for large-volume continuous mixing, coating, hydrating, and homogenizing applications
• Tight particle size control and scalable performance in oral solid dosage formulations

Final Dosage Forms & Secondary Services

• Nutraceutical finished dosage form capabilities
• Labeling and secondary packaging services
• Analytical services and regulatory support

Manufacturing Infrastructure

• Total capacity: 400,000 square feet of GMP manufacturing space across four facilities
• Locations: Haverhill (UK), Nottingham (UK), St. Louis (Missouri), and Seymour (Indiana)
• Scale: From grams to multi-ton production with seamless scale-up
• Regulatory track record: 30-year impeccable regulatory history

Quality & Compliance

• Operates under rigorous cGMP standards (21 CFR Parts 210/211, 110/111, 117)
• Quality by Design (QbD) philosophy with ICH Q8/Q9/Q10 implementation
• FDA-inspected facilities with successful recent inspections (St. Louis facility passed FDA inspection in 2025)
• Manufacturing site GMP approval by German authorities
• Kaizen and Lean manufacturing principles embedded across operations
• Culture of continuous improvement and operational excellence

Customer Base

Trusted CDMO partner for pharmaceutical, consumer health, OTC, and nutraceutical customers worldwide.